Pharmacy benefit manager Express Scripts, part of Cigna’s Evernorth subsidiary, will be adding Humira biosimilars to its formulary in 2023 as preferred products, which will be available to patients with inflammatory conditions.
Express Scripts adding Humira biosimilars to formulary
